Centers for Disease Control and Prevention: Malaria, Falciparum trials
The registry lists 11 Malaria, Falciparum studies with Centers for Disease Control and Prevention as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 3 1Phase 4 5No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Artemether-lumefantrine for Treatment of P. Falciparum Malaria in BrazilCompletedNCT02600767Not applicableResults posted
- Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in LiberiaCompletedNCT06300970Phase 4
- In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum MalariaCompletedNCT02637128Phase 4
- Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in MalawiCompletedNCT01326754Not applicable
- Assessing the Efficacy of Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria Infection in ChildrenCompletedNCT01082705Phase 3
- Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum MalariaCompletedNCT00425763Phase 4
- Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the PhilippinesCompletedNCT00229775Not applicable
- Assessing the Efficacy of Four Drug Combinations as the Next First-line Therapy for Uncomplicated Malaria in MalawiCompletedNCT00164710Phase 4
- Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in MalawiCompletedNCT00164359Phase 4
- Efficacy and Effectiveness of Combined Therapy for Uncomplicated Malaria Treatment in PeruCompletedNCT00164216
- Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: MalawiCompletedNCT00126906Not applicable